Brooks Laboratories Limited (NSE:BROOKS)
India · Delayed Price · Currency is INR 66.39
+0.64 (0.97%)
Nov 11, 2026, 1:52 PM IST
Brooks Laboratories Market Cap
Brooks Laboratories has a market cap or net worth of 1.96 billion as of November 10, 2026. It is the 36,549th most valuable company in the world and the 2,757th biggest in India. Its market cap has decreased by 35.66% in one year.
Market Cap
1.96B
Enterprise Value
1.37B
Revenue
795.39M
Global Rank
Country Rank
#2,757 India
PE Ratio
2.68
ChartMarket Cap Chart
Since September 5, 2011, Brooks Laboratories's market cap has increased from 105.21M to 1.96B, an increase of 1,758.79%. That is a compound annual growth rate of 21.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 1.96B | -17.16% |
| Dec 31, 2025 | 2.36B | -50.07% |
| Dec 31, 2024 | 4.73B | 25.45% |
| Dec 29, 2023 | 3.77B | 39.59% |
| Dec 30, 2022 | 2.70B | 8.92% |
| Dec 31, 2021 | 2.48B | 51.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jagsonpal Pharmaceuticals | 14.30B |
| Bafna Pharmaceuticals | 11.18B |
| Sigachi Industries | 10.42B |
| Amanta Healthcare | 7.89B |
| Valiant Laboratories | 6.06B |
| Nectar Lifesciences | 2.00B |
| Par Drugs and Chemicals | 1.39B |
| Balaxi Pharmaceuticals | 1.22B |